Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• CD40 is a TNF receptor family member typically found on the plasma membrane.
• Recent findings indicate CD40 also resides in the nucleus of B cells, including large B-cell lymphoma (LBCL) cells.
• The nuclear function of CD40 in B cells remains largely uncharacterized.

Purpose of the Study:

• To investigate the physiological role of nuclear CD40 in large B-cell lymphoma (LBCL).
• To determine the interaction partners and transcriptional targets of nuclear CD40 in LBCL cells.
• To explore the potential of targeting nuclear CD40 for lymphoma therapy.

Main Methods:

• Co-immunoprecipitation assays to identify nuclear CD40 interacting proteins.
• Chromatin immunoprecipitation followed by sequencing (ChIP-seq) to map CD40 and c-Rel binding sites.
• Reporter gene assays to assess promoter activity of NF-kappaB target genes.
• Analysis of normal B cells and LBCL patient samples.

Main Results:

• Nuclear CD40 interacts with the NF-kappaB subunit c-Rel, but not p65, in LBCL cells.
• Nuclear CD40 and c-Rel form complexes on the promoters of NF-kappaB target genes, including CD154, BLyS/BAFF, and Bfl-1/A1.
• Wild-type CD40, but not NLS-mutated CD40, enhances c-Rel-mediated BLyS/BAFF promoter activation and LBCL cell proliferation.
• Evidence supports a nuclear transcriptional role for CD40 and c-Rel in normal B cells and LBCL.

Conclusions:

• Nuclear CD40 and c-Rel cooperate to regulate genes involved in cell growth and survival in LBCL.
• This nuclear interaction is critical for lymphoma cell proliferation and survival mechanisms.
• Targeting the nuclear function of CD40 and c-Rel may offer novel therapeutic strategies for LBCL.